Bodhi Tree Biotechnology Inc (BDTB) Net Margin (2024 - 2026)
Bodhi Tree Biotechnology's (BDTB) quarterly Net Margin came in at 231.94% in Q2 2026, down 160.44% quarter-over-quarter from 89.06% in Q3 2025.
Analysis
Bodhi Tree Biotechnology Inc (BDTB) Net Margin (2024 - 2026) Analysis & Trends
Bodhi Tree Biotechnology (BDTB) has reported Net Margin for 3 consecutive years, with 231.94% the latest figure, recorded in Q2 2026.
- On a quarterly basis, Net Margin changed N/A year-over-year to 231.94% in Q2 2026; TTM through Jun 2026 was 489.11%, a N/A change from a year earlier, with the FY2025 full-year figure at 880.4%, down 70339.0% from the prior year.
- Net Margin was 231.94% for Q2 2026 at Bodhi Tree Biotechnology, down from 89.06% in the prior quarter.
- Over five years, Net Margin peaked at 89.06% in Q3 2025 and troughed at 1295.54% in Q4 2024.
- A 3-year average of 538.85% and a median of 231.94% in 2026 frame the typical range for Net Margin.
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -231.94% |
| Sep 30, 2025 | -89.06% |
| Dec 31, 2024 | -1,295.54% |